跳至主要内容
临床试验/NCT02474550
NCT02474550Unknown不适用

Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma

Ajou University School of Medicine24 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,000
试验地点
24
主要终点
incidence of febrile neutropenia

研究概览

简要总结

This study was designed to review clincal outcomes of Diffuse Large B Cell Lymphoma (DLBCL) treated with R-CHOP chemotherapy in the era of pegylated-filgrastim. The investigators will prospectively collect clinical data and treatment outcome of patients with DLBCL who use prophylactic pegylated-filgrastim.

详细描述

  • Newly diagnosed DLBCL patients treated with R-CHOP chemotherapy
  • Prphylactic peg-filgrastim on the day after chemotherapy

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 or older
  • newly diagnosed with DLBCL
  • R-CHOP chemotherapy
  • offer informed consent

排除标准

  • other subtype of NHL
  • concomitant other cancer
  • previous chemotherapy or radiotherapy

结局指标

主要结局

incidence of febrile neutropenia

时间窗: within 30 days

次要结局

  • incidence of chemotherapy-related adverse events other than febrile neutropenia(4 weeks after completion of chemotherapy)
  • Overall survival(2 year)

研究者

发起方
Ajou University School of Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Seong Hyun Jeong

Associate

Ajou University School of Medicine

研究点 (24)

Loading locations...

相似试验